Effects of the aggregation state of amphotericin B on its toxicity to mice.
about
In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with IntralipidTreatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycosesPreparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans.Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.Carrier effects on biological activity of amphotericin B.Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment.How can micelle systems be rebuilt by a heating process?Influence of diet on experimental toxicity of amphotericin B deoxycholate.Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy.Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.Update on nonoxynol-9 as vaginal spermicide.Coprecipitation of nonoxynol-9 with polyvinylpyrrolidone to decrease vaginal irritation potential while maintaining spermicidal potency.Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80.Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micellesReformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.Injectable in situ cross-linking hydrogels for local antifungal therapy.Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis.Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(DL-lactide-co-glycolide)/dextran graft copolymer.Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.Structural insights on biologically relevant cationic membranes by ESR spectroscopy.Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseasesChitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug Delivery
P2860
Q28369708-26118F63-5971-448F-9B81-89AD2606AA59Q33749073-B423E0B6-682B-4E9F-A3B3-23EEC5A4201AQ33749120-A4BC2451-CE42-4283-95A0-51211380EC6BQ33807138-83DA02B5-AFD7-4E36-BD4C-1B468B947ABCQ34417313-F29A22EE-31B1-48A4-8385-8A87DEE9E372Q35127147-6FE1EE4E-B721-4E22-82B4-150FC1DB149FQ35138378-462A924D-A3B9-4D7F-BED3-750F67F66496Q35168703-B051CF5B-1AA9-4F40-B47D-ADB74AAA0370Q35372581-61D353EB-8AEB-4BD8-8F4E-BD721EC7DE21Q35535451-8708F0E8-B22E-4D7A-A3BD-45C13E1ADC37Q35686909-200BA294-D091-4A70-8CE4-12A104068196Q35820200-7E8C976D-7682-4990-AF2F-2DF738AE6366Q35967724-5E35FDFA-CB0E-4521-8A97-564B8C80A816Q37005474-8E07F003-F709-48CE-8731-EF089A07C297Q37360574-B833198B-33E6-49C5-BEB4-CC1177422778Q37360941-F5BB727E-7A06-4B1B-B129-47567C06FDBFQ38937745-4B994FA0-5646-47DC-A412-54E9CAEFC7C3Q38967744-5DC3BA53-2B8B-41FA-A53D-308965B504FDQ39785217-60E22271-0F21-46E1-8077-48450C38092FQ39954346-8D4C64FE-4974-48B7-A390-57FB44580B4EQ40163020-5E28B294-3A72-48A0-BEF0-59181E47891CQ40330676-BC01675A-EBCB-4B75-A39E-12F1A0640A75Q40347592-EBDFE2A4-2DCD-4F4C-92E7-D6F8BEF1B3D8Q41703512-C3F624BD-1A49-48D2-AF30-6038BDAA8C98Q41915894-B60D2F93-7204-4795-ABA6-AEB920F283E1Q42391942-1224FDD1-22A9-4DA0-8DD3-0700D6559836Q42926826-B8C3C7B7-991B-462E-BD13-803AA60CDD92Q45204005-C4C93C69-17F1-4809-B3BA-79AED8264099Q46235143-551DF892-7C39-49BB-BD00-33BCC1CE650AQ46881980-5098B4EC-D2BF-4AB0-BBCF-DCBB50A685C5Q47115771-178E4799-636B-4061-B112-D835FDB7F910Q48234963-6F648A16-7BF4-41E5-A502-D7CF4A0CE0B5Q57347954-F4564632-56F3-4ACF-974B-C95836A00F0BQ58655855-FA3C7A82-E210-433D-9335-34326EE498A8
P2860
Effects of the aggregation state of amphotericin B on its toxicity to mice.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@ast
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@en
type
label
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@ast
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@en
prefLabel
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@ast
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@en
P2093
P2860
P356
P1476
Effects of the aggregation state of amphotericin B on its toxicity to mice.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.10.2310
P407
P577
1992-10-01T00:00:00Z